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Abstract
Background: Canine lobular orbital adenomas are benign tumors that arise from orbital glandular tissue and
extend into the orbit, conjunctiva, and third eyelid. Surgical excision is challenging and recurrence rates are high
following excision alone. Enucleation and exenteration reduces the likelihood of recurrence, but is a radical
therapeutic option for an otherwise visual and comfortable eye. Human papillomavirus causes 4.5% of worldwide
cancers in people and has been identified in up to 23% of benign salivary gland tumors. To date, the etiology of
canine lobular orbital adenomas has not been established and it is reasonable to consider canine papillomaviruses
as an associative agent with benign glandular tumors in dogs. Identification of the underlying etiology of these
tumors may help establish treatment or preventative measures. The purpose of this study was to evaluate
conjunctival and orbital tissue of phenotypically normal dogs and tissue from canine lobular orbital adenomas for
the presence of papillomavirus DNA.
Results: Thirty seven canine lobular orbital adenoma samples (36 formalin fixed paraffin embedded (FFPE) tissue
samples from 33 dogs and one freshly collected sample) were evaluated via polymerase chain reaction for the
presence of papillomavirus DNA. Conjunctival tissue samples, from 10 dogs with normal ocular examinations,
excised immediately following euthanasia, were used as phenotypically normal controls. Three FFPE and one freshly
collected tissue samples previously confirmed to be positive for papillomavirus DNA were used as positive controls.
PCR products verified positive controls. Papillomavirus DNA was not detected in fresh conjunctival tissue of the
phenotypically normal control dogs or in samples of fresh or FFPE canine lobular orbital adenoma tissue.
Conclusions: An association between papillomavirus and the development of canine lobular orbital adenomas is
unlikely. Further research is needed to evaluate if other viruses play a role in the pathogenesis of canine lobular
orbital adenomas.
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Background
Canine lobular orbital adenomas are benign tumors of
epithelial origin and can affect the conjunctiva, eyelids,
or third eyelid and extend into the orbit. They occur in
middle age to older dogs and have been reported in vari-
ous breeds [1]. These masses originate from glandular
tissue of suspected lacrimal or zygomatic salivary tissue
[1, 2]. They may be nodular or solid and are typically
lobulated and friable, extending into the orbit. Histo-
pathologic evaluation of these masses by Headrick et al.
showed lobulated and well-differentiated tissue of glan-
dular origin arising from either the lacrimal or zygo-
matic salivary gland. The neoplastic tissue lacks ductular
structures and the secretory pattern is mucoserous in
nature [1]. They can occur bilaterally and tend to be lo-
cally aggressive and frequently recur following surgical
excision [1].
Affected dogs are typically visual with no abnormal-
ities of the globe itself, but local disease can result in
complications due to orbital mass occupation. Complete
excision of these masses is difficult, and radical
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procedures such as exenteration to obtain clean margins
of excision are not ideal as they would result in blind-
ness [1]. Further investigation into microbial, viral, and
genetic triggers of these tumors is warranted. A better
understanding of the pathogenesis of canine lobular or-
bital adenoma could aid in both tumor prevention and
the development of less invasive, more effective
therapies.
Papillomaviruses are non-enveloped, double-stranded
DNA viruses of the Papillomaviridae family that infect
epithelial cells. Human papillomavirus (HPV) is esti-
mated to cause 4.5% of worldwide cancers and is associ-
ated with development of epithelial neoplasms in the
cervix, anus, penis, and head and neck [3–6]. Addition-
ally, HPV has been identified in salivary gland tumors [7,
8] as well as normal glandular tissue [9], however the
role of HPV in the etiology of these tumors has not been
determined as other studies have failed to identify HPV
in human salivary gland tumors [9–11]. Papillomaviruses
contain a single molecule of circular DNA which en-
codes several early genes involved in tumorigenesis, in-
cluding, E5, E6, and E7. Together, these genes drive
cellular transformation ultimately resulting in malignant
conversion. Specifically, E6 targets p53 for degradation
via the ubiquitin pathway; E7 binds to the retinoblast-
oma protein, inactivating it and resulting in downregula-
tion of tumor suppression and promotion of cellular
proliferation [4, 12–14]. Additionally, E5 activates or
blocks multiple signaling pathways and works in cooper-
ation with the other early gene oncoproteins to result in
cell proliferation, protection from apoptosis, and im-
mune evasion [15–19]. While the pathogenesis of high
risk HPV in human malignancies has been established,
the involvement of E5, E6, and E7 proteins and the exact
mechanism for tumorigenesis in dogs has yet to be fully
determined. However, Wang et al. illustrate that canine
papillomavirus type 2 uses an alternative domain to de-
grade the retinoblastoma protein and thus E7, of canine
papillomavirus type 2, is likely a component of cellular
transformation in dogs [13].
In addition, papillomavirus DNA encodes two late
genes, including the highly conserved L1 capsid protein
gene which is often a target of PCR amplification for
viral genome detection [20]. Papillomaviruses have been
detected in several epithelial tumors of animals: plaques,
papillomas, and squamous cell carcinomas of the skin,
cornea, and mucosa of the oral cavity and conjunctiva in
dogs, [21–28] equine sarcoids, [29] and cutaneous squa-
mous cell carcinomas and sarcoids in cats [30]. Vaccin-
ation with recombinant adenovirus vaccines expressing
the E1 and E2 genes of canine papillomavirus resulted in
protection from mucosal site warts induced by papillo-
mavirus in beagles [31]. Therefore, if papillomaviruses
are identified as causative agents of canine lobular
orbital adenomas then further investigation of papillo-
mavirus vaccines may be warranted.
Viral pathogens have not been evaluated as a causative
agent in cases of canine lobular orbital adenomas.
Therefore, the purpose of this study was to evaluate con-
junctival and orbital tissue from phenotypically normal
dogs and from canine lobular orbital adenoma tissue
samples for the presence of papillomavirus DNA. We
hypothesized that papillomavirus DNA would not be de-
tected in tissue from phenotypically normal dogs and
that papillomavirus DNA would be detected in canine
lobular orbital adenoma tissue samples.
Results
All dogs in the phenotypically normal control group
were mixed breed dogs and estimated to be between 2
and 9 years of age. All dogs were euthanized due to be-
havioral issues. No anterior segment changes were
present in any of the dogs in this group. In addition, all
normal control dogs were free of peri-ocular papillomas.
All formalin-fixed paraffin-embedded (FFPE) tissue
samples from the canine lobular orbital adenoma group
were confirmed canine lobular orbital adenomas via
histopathology by the comparative ocular pathology lab
of Wisconsin (COPLOW) utilizing the criteria described
by Headrick et al. [1]. The histopathology of one of the
tumors is shown in Fig. 1.
The average age of dogs with lobular orbital adenomas
was 10.5 years (range 6–16 years). The left eye was af-
fected in 17 cases, the right eye in 11 cases, and both
eyes in 4 cases; one case was presumed to be OU based
on follow-up; however, histopathology was not available
for the second eye. The affected eye, breed, age, and gen-
der of each dog is provided in Table 1. DNA quantity
and purity were deemed sufficient for PCR after evalu-
ation by Qubit and Nanodrop. Amplification of an
appropriate-sized band for GAPDH, a housekeeping
gene, was detected in all samples, confirming that DNA
extraction yielded DNA of sufficient quantity and quality
for PCR (Figs. 2 and 3) [32–34]. Polymerase chain reac-
tion results yielded no bands in the non-template nega-
tive controls and appropriate bands in the positive
controls (three canine papillomas and one equine sar-
coid). Papillomavirus DNA was not detected in fresh
conjunctival and orbital tissue of phenotypically normal
dogs. Also, papillomavirus DNA was not detected in
samples of fresh or FFPE canine lobular orbital adenoma
tissue (Figs. 4 and 5).
Discussion
This study is the first to evaluate papillomavirus’ role in
canine lobular orbital adenoma. Papillomavirus DNA
was not detected in any tissue from phenotypically nor-
mal dogs or dogs with canine lobular orbital adenomas.
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An association between papillomavirus and the develop-
ment of canine lobular orbital adenomas is unlikely.
Tumors of the lacrimal and salivary glands are rarely
reported in the veterinary literature, but include benign
adenomas, malignant adenocarcinomas, and tumors of
mixed epithelial and mesenchymal origin [35, 36]. Ca-
nine lobular orbital adenomas are rare benign orbital tu-
mors in dogs with suspected lacrimal gland origin;
however, zygomatic salivary gland or gland of the third
eyelid cannot be excluded as the gland of origin in these
cases [1]. These tumors can have devastating ocular con-
sequences due to difficulty obtaining complete excision
leading to subsequent recurrence. To date, an underlying
cause for these tumors has not been determined.
There are a number of benign tumors of lacrimal and
salivary gland origin. While the role of papillomavirus in
human salivary gland tumorigenesis is controversial,
HPV, including the more pathogenic strains HPV 16 and
18, has been identified in benign human salivary gland
tumors [7, 8, 37]. Several studies have detected HPV in
benign tumors of salivary gland origin, including pleo-
morphic adenomas, Warthin’s tumors, [8–10, 38] and
salivary gland oncocytomas [37]. Thus, it is reasonable
to evaluate benign glandular tumors in dogs for the
presence of canine papillomavirus.
Several other studies have evaluated normal and
abnormal canine ocular tissue for the presence of papil-
lomavirus. Papillomavirus has been detected in conjunc-
tival plaques and viral papillomas, and an eyelid
squamous cell carcinoma in dogs [23, 28, 39]. However,
Beckwith-Cohen et al. showed that papillomavirus was
not present in 10 conjunctival squamous papillomas or
normal conjunctival tissue from one dog [39]. Our
current study is consistent with the Beckwith-Cohen
study as papillomavirus was not present in normal con-
junctival tissue or tissue from canine lobular orbital
adenomas.
There are several explanations that support the lack of
detection of papillomavirus DNA in our samples. The
most likely is that papillomavirus is not a normal resi-
dent of canine conjunctival tissue and is not associated
with the development of these tumors and therefore,
papillomavirus DNA was not detected. However, fixation
in formalin can lead to DNA fragmentation, [40] which
may have impaired DNA amplification and led to false
negative results in the present study. However, this is
unlikely as several studies have detected papillomavirus
DNA, including canine papillomavirus 12 and a novel
virus closely related to CPV 16, via PCR with the FAP59
and FAP64 primers using FFPE tissue [41–43]. Addition-
ally, three of the positive control samples were from
FFPE tissue and this tissue was collected and processed
in the same manner as the lobular adenoma tissue, sug-
gesting that DNA fragmentation as a cause of the nega-
tive results is not likely to have occurred in this study.
Another explanation is that papillomavirus levels were
too low for detection and thus not detected. It is also
possible that the PCR primers used in this study failed
to detect papillomavirus DNA as these primers amplify
the gene of the L1 capsid which is conserved among
most, but not all papillomavirus families. These primers
have been shown to amplify canine papillomaviruses 1–5
and 7 [44]. Further, previous studies have shown that
viral DNA may lead to initial transformation of cells
and tumor development, but are not required for
maintenance of altered cells [45]. Thus it is possible
that papillomavirus DNA was present to initiate
tumor development, but was then lost resulting in
negative PCR results. However, this phenomena is
theorized to occur more commonly in malignant tu-
mors and since canine lobular orbital adenomas are
benign, this is unlikely to be the case [46–49]. Fi-
nally, another virus besides papillomavirus may be
associated with development of canine lobular orbital
Fig. 1 Canine lobular orbital adenoma. Photomicrograph illustrating
well-differentiated glandular tissue lacking ducts. The epithelial cells are
large and contain abundant cytoplasm and the nuclei are small and
round. H&E 100x (top image); 400x (bottom image). Photo courtesy of
Dr. Megan Climans and the Comparative Ocular Laboratory of Wisconsin
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adenomas. Further investigation of alternative infec-
tious or genetic etiologies is warranted.
Limitations of this study include the relatively small
sample size of both the orbital adenoma and phenotypic-
ally normal dogs. Further, affected FFPE tissue was com-
pared to freshly collected tissue from normal dogs
instead of FFPE tissue. While some may argue that a
better comparison would have been to compare the ca-
nine lobular orbital adenoma tissue to age, breed, and
sex matched FFPE conjunctival tissue sample, the au-
thors elected to use fresh tissue from phenotypically nor-
mal dogs as this approach yields the highest quality
Table 1 Signalment of each canine lobular orbital adenoma dog included in the study, including affected eye, breed, age, and
gender
Affected Eye Breed Age (years) Gender Neuter Status
1 OS Golden Retriever 12 Male Intact
2 OD Shepherd mix 10 Male Neutered
3 OS German Shepherd mix 8 Female Spayed
4 OS Mix 10 Female Spayed
5 OD Samoyed 11 Male Neutered
6 OS Labrador Retriever 11 Male Neutered
7 OS Boston Terrier 8 Female Spayed
8 OD Labrador Retriever 14 Female Spayed
9 OS Bichon Frise 12 Female Spayed
10 OD Labrador Retriever 7 Female Spayed
11 OS Labrador Retriever 8.3 Male Neutered
12 OD Dalmatian – – –
13 OD Australian Cattle Dog 6 Female Spayed
14 OS Samoyed 11 Female Spayed
15 OS Shih Tzu 9 Female Spayed
16 OD Mix 16 Male Neutered
17 OS Shih Tzu 10 Female Spayed
18 OS Cockapoo 8.5 Female Spayed
19 OS Labrador Retriever 12 Female Spayed
20 OS Labrador Retriever – Male Neutered
21 OS Samoyed 10 Female Spayed
22 OD Toy Poodle 12 Male Neutered
23 OD Wheaten Terrier – Male Neutered
24 OD Boston Terrier 13 Female Spayed
25 OD Samoyed 13 Female Spayed
26 OS Labrador Retriever 11 Female Spayed
27 OS Labrador Retriever 8 Female Spayed
28 OD Shih Tzu 12 Female Intact
OS
30 OD Miniature Poodle mix 9 Male Neutered
OS
32 OD Mix 10 Female Spayed
33 OU (OD) Golden Doodle 10 Male Neutered
34 OS Cockapoo 13 Female Spayed
35 OS Mix 11 Female Spayed
OD
Data unavailable, OS oculus sinister (left eye), OD oculus dextrus (right eye), OU oculus uterque (each eye) Data unavailable, OS oculus sinister (left eye), OD oculus
dextrus (right eye), OU oculus uterque (each eye)
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DNA for amplification. As discussed earlier, formalin fix-
ation and paraffin embedding can lead to cross-linking
and fragmentation of the DNA. Therefore, fresh tissue
from dogs euthanized at local humane shelters was used
to eliminate the possibility of altering the DNA and to
achieve the best representation of DNA from conjunc-
tival tissue.
Conclusions
In conclusion, papillomavirus DNA was not detected
in fixed or fresh tissue samples of canine lobular or-
bital adenoma tumors and an association between
papillomavirus and canine lobular orbital adenoma
development is unlikely. Further research is needed to
evaluate the etiology and pathogenesis of canine lobu-
lar orbital adenomas.
Methods
Phenotypically normal control group
Ten dogs, euthanized at local animal shelters for reasons
unrelated to this study, were identified for use as phenotyp-
ically normal controls. All dogs underwent an ophthalmic
examination of the anterior segment and adnexa prior to
euthanasia and tissue was collected if dogs were free of
gross ocular pathology. Excisional biopsies of conjunctival
and orbital tissues were aseptically obtained from the su-
perior and inferior conjunctival fornix of each eye immedi-
ately following euthanasia. After collection, fresh tissue was
flash frozen in liquid nitrogen and stored at − 80 °C until
DNA extraction.
Canine lobular orbital adenoma group
Thirty six formalin-fixed paraffin-embedded (FFPE) tis-
sue samples from 33 dogs previously diagnosed with
canine lobular orbital adenoma were obtained from the
Comparative Ocular Pathology Lab of Wisconsin
(COPLOW). The histopathologic criteria outlined by
Headrick et al. was used to confirm the diagnosis of ca-
nine lobular orbital adenoma for each tissue sample [1].
In addition, a fresh tumor sample, previously diagnosed
by COPLOW as a canine lobular orbital adenoma, was
collected for analysis, flash frozen in liquid nitrogen and
stored at − 80 °C until DNA extraction.
Fig. 2 PCR for canine GAPDH sequence from canine lobular orbital
adenoma FFPE samples. Amplicons were detected in all samples.
The arrowhead indicates the position of the 400 base pair amplicon
expected for this assay. NTC – Non-template control; CPAP – Canine
papillomavirus positive control samples
Fig. 3 PCR for GAPDH sequence from freshly collected
phenotypically normal canine conjunctival tissue samples. Amplicons
were detected in all samples. The arrowhead indicates the position
of the 400 base pair amplicon expected for this assay. NTC - Non-
template control; CPAP – Canine papillomavirus positive
control samples
Fig. 4 PCR for papillomaviral sequence from canine lobular orbital
adenoma FFPE samples. Amplicons were detected in the positive
control samples. No amplicons were detected in any of the FFPE
orbital adenoma samples. The arrowhead indicates the position of
the 480 base pair amplicon expected for this assay. NTC – Non-
template control; CPAP – Canine papillomavirus positive
control samples
Fig. 5 PCR for papillomaviral sequence from freshly collected
phenotypically normal canine conjunctival tissue samples. Amplicons
were detected in the positive control samples. No amplicons were
detected in any of the normal conjunctival samples. The arrowhead
indicates the position of the 480 base pair amplicon expected for
this assay. NTC - Non-template control; CPAP – Canine
papillomavirus positive control samples
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DNA extraction and polymerase chain reaction
Each FFPE tissue block was aseptically sectioned into
10 μm tissue scrolls. Genomic DNA was extracted from
all samples, using the commercially available Qiagen
DNeasy Blood and Tissue DNA Extraction Kit (Qiagen,
N.V., Hilden, Germany) for the fresh tissue samples and
the commercially available Qiagen QIAmp DNA FFPE
Tissue Kit (Qiagen, N.V., Hilden, Germany) for the FFPE
samples. The genomic DNA was quantified using the
Qubit 2.0 fluorometer (Invitrogen, Life Technologies,
Carlsbad, CA, USA) following the manufacturer’s protocol
for the Quant-iT dsDNA HS Assay. Additionally, DNA
quantity and purity were assessed using the NanoDrop
2000 Spectrophotometer (Thermo Fisher Scientific, Wil-
mington, DE, USA) following the manufacturer’s protocol.
The purity of each DNA sample was determined by meas-
uring the absorbance ratio at 260/280 nm. DNA was
stored at − 20 °C until PCR was performed.
A specific 480 base pair fragment of the well-
conserved papillomavirus L1 capsid protein was ampli-
fied by PCR using a set of degenerate primers, FAP59
and FAP64 (Table 2) [41]. This PCR primer set has been
used extensively to sensitively detect papillomaviruses
from a variety of animals including feline, equine, and
canine neoplastic tissue samples [22, 29, 42, 50–52].
Non-template samples served as negative controls.
Three FFPE tissue samples (two from canine viral papil-
lomas and one from an equine sarcoid) and one fresh
canine viral papilloma served as positive controls. Each
PCR mixture contained 50 ng of DNA template for the
FFPE samples and 5 ng of DNA template for the fresh
tissue samples, 1.25 μL of the FAP59 and FAP64 primers
(concentration 10 μM), 1.5 mM MgCl2, 0.2 mM each
dNTP (New England BioLabs, Ipswich, MA, USA), 1.25
U Taq DNA polymerase (Invitrogen, Life Technologies,
Carlsbad, CA, USA), and appropriate volumes of nucle-
ase free water to reach a total volume of 50 μL for each
reaction. All PCR reactions were performed in duplicate
in an automated thermocycler (C1000 Thermal Cy-
cler, Bio-Rad Laboratories, Hercules, CA, USA), using
the following parameters: 10 min at 94 °C and then
45 cycles of 90 s at 94 °C, 90 s at 50 °C, 90 s at 72 °C,
and finally 5 min at 72 °C. Polymerase chain reaction
products were combined with Gel Red (GelRed® Nu-
cleic Acid Gel Stain, Biotium, Inc., Fremont, CA,
USA), electrophoresed in 1.5% agarose gel, and im-
aged in UV light to determine the presence of the
specific amplicon band.
To confirm the presence of DNA in each sample, an ap-
proximate 400 base pair segment of the glyceraldehyde-3-
phosphate dehydrogenase (GADPH) gene was amplified
using canine GAPDH primers as previously described
[32–34]. Each PCR mixture contained 50 ng of DNA tem-
plate, 1.0 μL each of the forward and reverse primers (con-
centration 10 μM), 2.5 μM MgCl2, 0.2 mM each dNTP
(New England BioLabs, Ipswich, MA, USA), 2.5 U Taq
DNA polymerase (Invitrogen, Life Technologies, Carlsbad,
CA, USA), and appropriate volumes of nuclease free water
to reach a total volume of 25 μL for each reaction. Poly-
merase chain reaction was performed in the aforemen-
tioned automated thermocycler using the following
parameters: 5 min at 94 °C and then 32 cycles of 60 s at
94 °C, 60 s at 58 °C, 60 s at 72 °C, and finally 5min at
72 °C. Polymerase chain reaction products were combined
with Gel Red (GelRed® Nucleic Acid Gel Stain, Biotium,
Inc., Fremont, CA, USA), electrophoresed in 2% agarose
gel, and imaged in UV light to determine the presence of
the specific amplicon.
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